Skip to main content

Expanded Admission Screening Protocol for Candida Auris Beneficial

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 10, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, Nov. 8, 2024 -- Health care facilities should consider initiating or expanding admission screening for Candida auris based on community prevalence rates, according to a study published online Oct. 31 in the American Journal of Infection Control.

Aaron Cheng, M.P.H., from Mount Sinai Beth Israel in New York City, and colleagues examined the utility of expanding a C. auris admission screening protocol at an acute care hospital to screen all patients presenting from any skilled nursing facility. The analysis included 591 patients screened on admission for C. auris from January 2022 through September 2023.

According to the researchers, 14 cases were identified (2.4 percent), including nine cases presenting with tracheostomies or ventilator dependence, and were classified as high-risk. At the time of screening, five cases were considered low-risk. Under the prior criteria, eight of the newly identified cases would not have been screened.

"Our study supports the need for hospitals to adopt expanded screening protocols to enhance infection control practices," coauthor Scott Lorin, M.D., of Mount Sinai Brooklyn and Icahn Mount Sinai, said in a statement. "Broader screening not only identifies cases early, but also allows for targeted precautions, reducing the risk of hospital-based outbreaks. The implementation of proactive protocols, based on community prevalence rates, can be a key tool in controlling the spread of this emerging global health threat."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted November 2024

Read this next

Burden of Superficial Cutaneous Fungal Infection Quantified in U.S.

FRIDAY, Nov. 15, 2024 -- The burden of superficial cutaneous fungal infections (SCFIs) among outpatient visits in the United States is high and increasing, according to a study...

First Cases of Sexually Transmitted Ringworm Reported in the U.S.

THURSDAY, Oct. 31, 2024 -- Doctors in New York City are chronicling the first known U.S. cases of sexually transmitted ringworm (Trichophyton mentagrophytes). Until now...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.